STAT reports:
A panel of outside experts on Thursday recommended the Food and Drug Administration issue an emergency use authorization to the Covid-19 vaccine being developed by Pfizer and BioNTech, a vaccine that appeared to be highly efficacious in a Phase 3 clinical trial.
The vote came after a long day in which members of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, discussed a wide range of issues related to …
The post STAT: FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine appeared first on The Loadstar.
Source: The Loadstar
Be the first to comment on "STAT: FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine"